Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT02160106
Title First in Human Dose Escalation Study of TEW-7197 in Subjects With Advanced Stage Solid Tumors
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors MedPacto, Inc.
Indications
Therapies
Age Groups: adult
Covered Countries USA

Facility Status City State Zip Country Details
Durham North Carolina 27710 United States Details
Nashville Tennessee 37203 United States Details
Nashville Tennessee 37232 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field